Therapeutic brain concentration of the NMDA receptor antagonist amantadine

This publication has 31 references indexed in Scilit:

• Are NMDA antagonistic properties relevant for antiparkinsonianlike activity in rats?—Case of amantadine and memantine
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1994
• Evidence for Lysosomotropism of Memantine in Cultured Human Cells: Cellular Kinetics and Effects of Memantine on Phospholipid Content and Composition, Membrane Fluidity and β‐Adrenergic Transmission
  Basic & Clinical Pharmacology & Toxicology, 1993
• Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity
  Journal of Neuroscience, 1992
• Amantadine sulphate in treating Parkinson's disease: Clinical effects, psychometric tests and serum concentrations
  Zeitschrift für Neurologie, 1989
• Clinical Pharmacokinetics of Amantadine Hydrochloride
  Clinical Pharmacokinetics, 1988
• Amantadine-induced lipidosis. A cytological and physicochemical study
  Toxicology, 1987
• Effects of exogenous amines on mammalian cells, with particular reference to membrane flow
  Biochemical Journal, 1984
• A Controlled Trial of Amantadine in Drug-Induced Extrapyramidal Disorders
  Archives of General Psychiatry, 1976
• Lysosomotropic agents
  Biochemical Pharmacology, 1974
• Acute Toxic Psychosis From Suicidal Overdosage of Amantadine
  Archives of Neurology, 1971